acetaminophen has been researched along with oseltamivir in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chang, HR; Chen, CC; Chen, SC; Lee, MC; Lee, YT; Liu, KS | 1 |
| Arizono, K; Matsuo, H; Sakamoto, H; Shinohara, R | 1 |
| Fujiyama, T; Hirakawa, S; Ito, T; Shimauchi, T; Tokura, Y; Umayahara, T | 1 |
| Miyazaki, C; Momoi, M; Ohkusa, Y; Okabe, N; Sugawara, T; Taniguchi, K | 1 |
| Abd El Ghafar, MS; Abd-Elsalam, S; Abdo, EF; Ahmed, OA; Alboraie, M; Esmail, ES; Khalaf, M; Medhat, MA; Serangawy, GN; Soliman, S | 1 |
1 review(s) available for acetaminophen and oseltamivir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for acetaminophen and oseltamivir
| Article | Year |
|---|---|
RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.
Topics: Acetaminophen; Adult; Antiviral Agents; Betacoronavirus; Cephalosporins; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Repositioning; Egypt; Female; Humans; Hydrocortisone; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome | 2020 |
5 other study(ies) available for acetaminophen and oseltamivir
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Rhabdomyolysis following pandemic influenza A (H1N1) infection.
Topics: Acetaminophen; Adolescent; Alanine Transaminase; Analgesics, Non-Narcotic; Antiviral Agents; Aspartate Aminotransferases; Creatine Kinase; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; L-Lactate Dehydrogenase; Oseltamivir; Pandemics; Rhabdomyolysis | 2010 |
Behavior of pharmaceuticals in waste water treatment plant in Japan.
Topics: Acetaminophen; Amoxicillin; Ampicillin; Carbamazepine; Chromatography, Liquid; Diclofenac; Famotidine; Japan; Ketoprofen; Losartan; Mass Spectrometry; Oseltamivir; Sewage; Trimethoprim; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2011 |
Paediatric acute generalized exanthematous pustulosis induced by paracetamol with high serum levels of interleukin-8 and -22: a case report.
Topics: Acetaminophen; Acute Generalized Exanthematous Pustulosis; Antipyretics; Antiviral Agents; Biopsy; Drug Eruptions; Enzyme-Linked Immunosorbent Assay; Glucocorticoids; Humans; Influenza, Human; Interleukin-22; Interleukin-8; Interleukins; Male; Oseltamivir; Prednisolone; Skin; Treatment Outcome; Up-Regulation | 2013 |
Association of severe abnormal behavior and acetaminophen with/without neuraminidase inhibitors.
Topics: Acetaminophen; Adolescent; Age Factors; Antiviral Agents; Behavioral Symptoms; Child; Drug Therapy, Combination; Enzyme Inhibitors; Female; Guanidines; Humans; Incidence; Influenza, Human; Japan; Male; Neuraminidase; Oseltamivir; Pyrans; Risk Factors; Sialic Acids; Zanamivir | 2019 |